Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-28 | Thomas B. King has served as a director since March 2023. ... Mr. King has served as an independent biotechnology consultant and advisor since August 2016. ... The determination was made that Mr. King should serve on our Board of Directors due to his extensive leadership experience in the pharmaceutical and biopharmaceutical industry, including experience with small and large development stage pharmaceutical companies, and his experience serving on several boards of directors of both public and private companies. |
| 2024-04-26 | Thomas B. King has served as an independent biotechnology consultant and advisor since August 2016. ... The determination was made that Mr. King should serve on our Board of Directors due to his extensive leadership experience in the pharmaceutical and biopharmaceutical industry, including experience with small and large development stage pharmaceutical companies, and his experience on the boards of directors of both public and private companies. |
Data sourced from SEC filings. Last updated: 2026-02-03